Buyer validation · CACHED
Top Opportunities
These are not all the assets HiveProspect found. This view contains only the few that pass every existing decision gate.
No buyer-ready assets established yet
The current public evidence assessments do not support a qualified shortlist. UNKNOWN is not a pass. We have not lowered the bar to fill five slots.
Next decision: establish scoped human treatment evidence, a feasible decisive experiment, transferable rights and market support before allocating acquisition capital. No defensible seller price or next-study budget follows from this empty result.
Analyze an Asset Inspect unresolved discovery leadsInspect diligence candidates and evidence gaps
What survived each gate?
| Sequential stage | Remaining observations |
|---|---|
| Assessed records | 877 |
| Human Signal | 0 |
| Cheap Truth | 0 |
| Clean Rights | 0 |
| Market Pull | 0 |
Human Signal → Cheap Truth → Clean Rights / Acquirability → Market Pull. Rescueability and the stopping explanation cannot replace a missing gate. Why now remains UNKNOWN without a sourced catalyst. No publication-volume bonus, name exception or private customer scenario feeds this public selection.
A supported gate is still a scoped assessment, not proof of title, clinical benefit or a buy recommendation. Cached coverage is partial; this result does not establish that no suitable asset exists anywhere.
Inspect the evidence standards